Literature DB >> 10096039

Molecular mapping of epitopes involved in ligand activation of the human receptor for the neuropeptide, VIP, based on hybrids with the human secretin receptor.

B Olde1, A Sabirsh, C Owman.   

Abstract

Receptors for the neurotransmitter and neuroendocrine peptides, vasoactive intesinal peptide (VIP) and secretin, both belong to the Type B subfamily of G-protein-coupled receptors. This group is evolutionally as well as structurally distinct from the much larger Type A, or rhodopsin-type, subfamily. We have mapped the ligand-activating epitopes of the human VIP1 receptor by the use of hybrid receptor constructs with the human secretin receptor. Twelve chimeras were synthesized the successively replacing portions of the former receptor with corresponding portions of the latter receptor, or by interchanging the first extracellular loops. Each of the different chimeric receptor DNAs were then expressed in murine reporter cells, and their ability to activate cAMP production was investigated on stimulation with the respective natural peptide ligands. We stimulated the reporter cells with secretion or VIP following transient expression of the receptor chimeras. The experiments indicated that there are two molecular domains of importance for the recognition and activation of these peptides, namely, the inner portion of the extracellular tail and the first extracellular loop of the two receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10096039     DOI: 10.1385/JMN:11:2:127

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  21 in total

1.  "Megaprimer" method of PCR: increased template concentration improves yield.

Authors:  S Barik; M S Galinski
Journal:  Biotechniques       Date:  1991-04       Impact factor: 1.993

2.  The "megaprimer" method of site-directed mutagenesis.

Authors:  G Sarkar; S S Sommer
Journal:  Biotechniques       Date:  1990-04       Impact factor: 1.993

3.  Generating bacteriophage lambda sublibraries enriched for rare clones.

Authors:  M Lardelli; U Lendahl
Journal:  Biotechniques       Date:  1994-03       Impact factor: 1.993

4.  Improvement of the gene splicing overlap (SOE) method.

Authors:  B Lefebvre; P Formstecher; P Lefebvre
Journal:  Biotechniques       Date:  1995-08       Impact factor: 1.993

5.  Glucagon.glucagon-like peptide I receptor chimeras reveal domains that determine specificity of glucagon binding.

Authors:  J J Buggy; J N Livingston; D U Rabin; H Yoo-Warren
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

6.  Construction of chimeric molecules by a two-step recombinant PCR method.

Authors:  G Pont-Kingdon
Journal:  Biotechniques       Date:  1994-06       Impact factor: 1.993

7.  Molecular cloning and expression of a human secretin receptor.

Authors:  D R Patel; Y Kong; S P Sreedharan
Journal:  Mol Pharmacol       Date:  1995-03       Impact factor: 4.436

8.  Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family.

Authors:  G V Segre; S R Goldring
Journal:  Trends Endocrinol Metab       Date:  1993-12       Impact factor: 12.015

9.  Platelet-activating factor stimulation of peptidoleukotriene release: inhibition by vasoactive polypeptide.

Authors:  B B Beaubien; J R Tippins; H R Morris
Journal:  Biochem Biophys Res Commun       Date:  1984-11-30       Impact factor: 3.575

10.  Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes.

Authors:  S A Hjorth; K Adelhorst; B B Pedersen; O Kirk; T W Schwartz
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

View more
  2 in total

1.  Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling.

Authors:  Laurence J Miller; Quan Chen; Polo C-H Lam; Delia I Pinon; Patrick M Sexton; Ruben Abagyan; Maoqing Dong
Journal:  J Biol Chem       Date:  2011-03-16       Impact factor: 5.157

2.  Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.

Authors:  Ulf Karlsson; Liselotte Antonsson; Johanna Repits; Patrik Medstrand; Christer Owman; Karin Kidd-Ljunggren; Lars Hagberg; Bo Svennerholm; Marianne Jansson; Magnus Gisslén; Bengt Ljungberg
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.